MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Lipid metabolism"

  • MDS Virtual Congress 2021

    PLA2G6-Associated Neurodegeneration: A Continuum of Phenotypes

    D. Shah-Zamora, M. Bailey (Chicago, USA)

    Objective: To characterize the spectrum of phenotypes of PLA2G6-associated neurodegeneration in a single patient. Background: The phospholipase A2 Group VI (PLA2G6) gene encodes a cytosolic and…
  • MDS Virtual Congress 2020

    The role of polymorphic allelic variants of the VEGFα and TGFβ gene in the development of cerebrovascular disorders in patients with metabolic syndrome

    S.h Shokhimardonov, S.h Xudjanov, F. Shermuhammedova, S.h Kuzieva (Tashkent, Uzbekistan)

    Objective: The aim of the study was to understand the link between the VEGFα and TGFβ genes in the development of stroke in patients with…
  • MDS Virtual Congress 2020

    Sensitive biomarker of Parkinson’s disease linked to mutations in the glucocerebrosidase gene

    S. Pchelina, M. Nikolaev, A. Kopytova, G. Baydakova, K. Senkevich, I. Miliukhina, T. Usenko, A. Emelyanov, E. Zakharova (St.Petersburg, Russian Federation)

    Objective: To find a biomarker for development of Parkinson’s disease (PD) in carriers of mutations in the glucocerebrosidase gene (GBA). Background: Mutations in the GBA…
  • MDS Virtual Congress 2020

    Oral Venglustat in Parkinson’s Disease Patients With a GBA Mutation: Study Design of Part 2 of the MOVES-PD Trial and Patient Characteristics

    M.J Peterschmitt, T. Gurevich, T. Gasser, H. Saiki, S. Isaacson, C. Waters, A.M Wills, S. Hassin-Baer, T. Simuni, N. Hattori, S. Gaemers, S.P Sardi, S. Saubadu, P. Minini, T. Fischer (Cambridge, MA, USA)

    Objective: Describe the study design of Part 2 of the MOVES-PD trial (NCT02906020), and report patient characteristics. Background: Mutations in the glucocerebrosidase (GBA) gene are…
  • MDS Virtual Congress 2020

    Correlation and comparison of the lipid profile and the body fat mass in people with Parkinson’s disease submitted to three physical therapies

    A.F Fagundes, E.M Monteiro, M.C Casal, M.D Delabary, A.Z Zanardi, F.B Boeno, S.M Munhoz, R.M de Menezes, A.O de Oliveira, F.M Martinez, L.T Tartaruga, A.H Haas (Porto Alegre, Brazil)

    Objective: To correlate and to compare changes on the lipid profile (LP) and on the body fat mass in people with Parkinson's disease (PD) submitted…
  • MDS Virtual Congress 2020

    Post mortem fatty acid abnormalities in the cerebellar cortex of patients with essential tremor

    K. Melançon, L. Berthiaume, C. Tremblay, P. Juline, A. Rajput, A. Rajput, F. Calon (Quebec, QC, Canada)

    Objective: The objective of the study was to compare fatty acids (FA) profiles within different fractions of phospholipids retrieved from the cerebellum of patients who…
  • 2019 International Congress

    Synaptic dysfuncion in a Drosophila model of PARK14

    T. Hatano, A. Mori, T. Inoshita, K. Fukushima-Shiba, T. Koinuma, C. Yamashita, Y. Imai, N. Hattori (Tokyo, Japan)

    Objective: To investigate the association between lipid metabolism and synaptic function in Parkinson's disease (PD) due to PLA2G6 mutations. Background: The nervous system is enriched…
  • 2019 International Congress

    Parkinson’s disease-associated mutations of PLA2G6 alters the membrane dynamics and α-synuclein stability

    a. Mori, T. Hatano, T. Inoshita, K. Shiba-Fukushima, T. Koinuma, C. Yamashita, A. Okuzumi, Y. Imai, n. Hattori (Tokyo, Japan)

    Objective: To investigate the mechanism of α-synuclein (α-Syn) aggregation. Background: PLA2G6 has been isolated as the gene responsible for an autosomal recessive form of Parkinson’s…
  • 2019 International Congress

    The role of lipid metabolism in mouse models of Parkinson’s disease

    M. Trabjerg, D. Andersen, P. Huntjens, K. Mørk, M. Skjønnemand, M. Oklinski, A. Mørkholt, I. Huijbers, C. Pritchard, L. Kroese, J. Nieland (Aalborg, Denmark)

    Objective: To investigate the role of lipid metabolism and the effect of blocking carnitine palmitoyl-transferase 1 (CPT1) in toxic and genetically mouse models of Parkinson’s…
  • 2019 International Congress

    Abnormal Gait in Cerebrotendenious Xanthomatosis a case report

    H. Amer, S. Ali, S. Sherif, S. El-Jaafary (Cairo, Egypt)

    Objective: To identify patients with Cererotendenious xanthomatosis. To present the neurological spectrum of the disease. Background: Cerebrotendenious xanthomatosis is a rare lipid storage disease due…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley